Nicotinamide Mononucleotide (NMN) Market Size/Share To Surpass USD 428.14 Million By 2030: Exactitude Consultancy


(MENAFN- EIN Presswire)

Nicotinamide Mononucleotide (NMN) Industry

Unlocking Potential: Exploring the Health Benefits and Anti-aging Properties of Nicotinamide Mononucleotide (NMN) in Biomedical Research

Surging demand in the Nicotinamide Mononucleotide (NMN) market driven by its potential anti-aging properties and rising health consciousness” - Exactitude Consultancy

LUTON, BEDFORDSHIRE, UNITED KINGDOM, April 24, 2024 /EINPresswire / -- Catapult Your Business To Fore, Gain Competitive Advantage

The Latest Research report on“global Nicotinamide Mononucleotide (NMN) Market Report 2023 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029” offers strategic visions into the global Nicotinamide Mononucleotide (NMN) market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2023 to 2029.

"Increasing Availability Of High-Quality Supplements From Reputable Manufacturers Boost the Market Expansion"

There is definitely cause for excitement over the most recent trend in the nicotinamide mononucleotides (NMN) market! The demand for this supplement has surged as more and more individuals become aware of the possible health advantages of NMN. Given that NMN has been demonstrated to have anti-aging qualities, increase energy levels, and even enhance cognitive function, it comes as no surprise. The expanding availability of top-notch supplements from reliable suppliers is one of the most significant trends in the NMN industry. Users of these supplements may be sure they're receiving the most strong and most effective supplement because it's frequently prepared with pure, pharmaceutical-grade NMN. The use of NMN in conjunction with other dietary supplements or substances, such as resveratrol or metformin, is another approach that is gaining popularity. This strategy is predicated on the notion that these compounds complement each other to increase the advantages of NMN. .

The global nicotinamide mononucleotide (NMN) market size is projected to reach USD 428.14 million by 2030, from USD 210.64 million in 2023, at a CAGR of 8.2% during 2023-2030.

Click Here to Access a Free Sample Report

#request-a-sample

Some of the important players in Nicotinamide Mononucleotide (NMN) market are:

NMN market are GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, Bontac, Shandong Sihuan Pharmaceutical, EffePharm, Zhejiang Jiahua Pharmchemicals among and other.

Nicotinamide Mononucleotide (NMN) Market Segmentation:

This research report categorizes the Nicotinamide Mononucleotide (NMN) market into the following segments and subsegments:

NMN Market By Type, 2020-2030, ( USD Million) (Kilotons)

Content Below 98%

Content Above 98%

NMN Market By Application, 2020-2030, (USD Million) (Kilotons)

Health Care Products

Cosmetics

The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.

Region enclosed are: North America, Europe, Asia Pacific, Oceania, South America, geographical region & continent

Country Level Break-Up: u. s., Canada, Mexico, Brazil, Argentina, Colombia, Chile, Nigeria, Tunisia, Morocco, Germany, uk (UK), Holland, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, China, Japan, Taiwan, South Korea, Singapore, India and Australia etc.

If you want to know more:

The market drivers for the Nicotinamide Mononucleotide (NMN) Market can be influenced by various factors. These may include:

Growing Interest in Anti-Aging Solutions: As the world's population ages, so does the demand for goods and supplements that promote ageing in a healthful manner. Consumers looking for anti-aging remedies may find NMN appealing because of its probable function in activating sirtuins, a class of proteins linked to longevity and cellular health.

Increasing Awareness of Health and wellbeing: As consumers place more value on health and wellbeing, they are actively looking for solutions that will help them stay in good health and fend against age-related illnesses. These consumer preferences are supported by NMN's alleged benefits, which include enhanced metabolism, energy production, and DNA repair.

Developments in Research and Development: Current studies and clinical trials pertaining to NMN are continuing to reveal its possible health advantages and modes of action. Market demand is driven by growing consumer confidence in NMN as scientific evidence of its safety and efficacy mounts.

Market Expansion for Dietary Supplements: NMN is frequently sold as a dietary supplement, and the worldwide market for dietary supplements has been developing rapidly as a result of rising consumer knowledge of preventative healthcare and the rising incidence of chronic illnesses. The dietary supplement industry's growth is aided by the addition of NMN to product formulations.

A supportive regulatory environment is being created by regulatory bodies in several nations for the marketing and sale of dietary supplements that contain NMN. A clear regulatory framework promotes market expansion by giving manufacturers and customers confidence in the quality and safety of NMN goods.

Growing Investment and Strategic Alliances: Pharmaceutical, biotechnology, and nutraceutical companies are making investments in the NMN market. Industry participants engage in strategic alliances and collaborations with the objective of expediting product development, optimising distribution channels, and augmenting market penetration.

Several factors can act as restraints or challenges for the Nicotinamide Mononucleotide (NMN) Market. These may include:

High manufacturing expenses: NMN is produced using sophisticated procedures and premium raw materials, which adds to the manufacturing expenses. Some consumers may find the cost of NMN products to be prohibitive, which would restrict market penetration, particularly in price-sensitive economies.

Limited Clinical Evidence: There is currently little clinical evidence to support the safety and efficacy of NMN in humans, despite encouraging preclinical studies and animal research suggesting possible health advantages. The absence of solid clinical evidence could cause consumers and healthcare professionals to doubt NMN's efficacy, which would limit market expansion.

Regulatory Uncertainty: Regulators from all around the world are still assessing the effectiveness and safety of NMN as a component of dietary supplements. Manufacturers and distributors may have difficulties if regulatory requirements and compliance standards for NMN products are unclear. This could impede their ability to expand their market reach and make investments in product development.

Competitive Landscape: Alternative anti-aging and health supplements such as resveratrol, coenzyme Q10 (CoQ10), nicotinamide riboside (NR), and other nutraceuticals with comparable health benefits compete with the NMN industry. The market share and profitability of NMN goods may be restricted by fierce rivalry within the industry.

Perception of Novelty and Safety: The public may not be fully aware of NMN's advantages and safety profile because it is a relatively new substance in the consumer health industry. Some consumers may be discouraged from using NMN products due to worries regarding the long-term safety and possible negative consequences of NMN supplementation, particularly in the lack of thorough safety evidence.

Supply Chain Restrictions: Product quality, consistency, and cost may be impacted by the accessibility of premium raw materials and the stability of the NMN supply chain. The dependability and scalability of NMN manufacturing may be impacted by supply chain disruptions, changes in the price of raw materials, and problems with quality control, creating difficulties for suppliers and manufacturers.

Key Questions Answered in This Report


(1) What was the size of the global Nicotinamide Mononucleotide (NMN) market in 2022?

(2) What is the expected growth rate of the global Nicotinamide Mononucleotide (NMN) market during 2023-2028?

(3) What are the key factors driving the global Nicotinamide Mononucleotide (NMN) market?

(4) What has been the impact of COVID-19 on the global Nicotinamide Mononucleotide (NMN) market?

(5) What are the key regions in the global Nicotinamide Mononucleotide (NMN) market?

(6) Who are the key players/companies in the global Nicotinamide Mononucleotide (NMN) market?

Customization Scope-

Free report customization (equivalent up to 4 analysts working days) with Nicotinamide Mononucleotide (NMN) Report purchase. Addition or alteration to country, regional & segment scope.
In case of any Queries or Customization Requirements, please connect with our sales team, who will ensure that your requirements are met.

Do You Have Any Query or Specific Requirement? Request for Custom Research:

Also From This Source

Regional Links:

Inquire:

Irfan T
Exactitude Consultancy
+1 704-266-3234
email us here
Visit us on social media:
Twitter
LinkedIn

MENAFN24042024003118003196ID1108131009


EIN Presswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.